SN-38 is a potent antineoplastic agent belonging to the camptothecin class, widely researched in clinical trials for the treatment of advanced solid tumors, small cell lung cancer, metastatic colorectal… Read more
SN-38 is a potent antineoplastic agent belonging to the camptothecin class, widely researched in clinical trials for the treatment of advanced solid tumors, small cell lung cancer, metastatic colorectal cancer, and triple-negative breast cancer. As the active metabolite of irinotecan, this compound requires rigorous analytical monitoring to ensure therapeutic safety and efficacy. This category provides essential reference standards, including stable isotope labelled compounds and key metabolites like SN-38 glucuronide, designed to support comprehensive analytical testing. Laboratories rely on these high-quality materials for impurity profiling, method validation, and precise pharmacokinetic studies. By utilizing these deuterated reference materials, researchers can perform accurate quantification and structural elucidation during quality control processes, ensuring reliable data that avoids interference with endogenous biological signals in complex matrices.